Breaking News Instant updates and real-time market news.

CAVM

Cavium

$55.00

0.11 (0.20%)

, LRCX

Lam Research

$107.54

0.59 (0.55%)

07:03
11/28/16
11/28
07:03
11/28/16
07:03

Credit Suisse to hold a conference

20th Annual Technology, Media & Telecom Conference is being held in Scottsdale, Arizona on November 28-December 1 with company-hosted dinners being held on November 28 followed by webcasted company presentations to begin on November 29.

CAVM

Cavium

$55.00

0.11 (0.20%)

LRCX

Lam Research

$107.54

0.59 (0.55%)

LOGI

Logitech

$24.53

0.13 (0.53%)

MU

Micron

$20.13

0.22 (1.11%)

MXIM

Maxim Integrated

$40.20

0.24 (0.60%)

ULTI

Ultimate Software

$211.30

2.2 (1.05%)

  • 28

    Nov

  • 05

    Dec

  • 07

    Dec

  • 08

    Dec

  • 21

    Dec

CAVM Cavium
$55.00

0.11 (0.20%)

09/20/16
SUSQ
09/20/16
INITIATION
Target $65
SUSQ
Positive
Cavium initiated with a Positive at Susquehanna
Susquehanna analyst Christopher Rolland initiated Cavium with a Positive and a $65 price target given new product offerings that address the massive greenfield markets.
10/31/16
ROTH
10/31/16
NO CHANGE
Target $65
ROTH
Buy
Cavium price target raised to $65 from $59 at Roth Capital
Roth Capital analyst Brian Alger raised his price target for Cavium to $65 from $59 as he believes it is regaining its stride as a leading growth company. Further, the analyst thinks the September quarter saw "strong" end market demand for Cavium's solutions. He reiterates a Buy rating on the shares.
11/02/16
BMUR
11/02/16
NO CHANGE
Target $63
BMUR
Buy
Cavium price target raised to $63 from $57 at Brean Capital
Brean Capital analyst Mike Burton raised his price target on Cavium to $63 from $57 following its Q3 results. The analyst cited its strong product cycles in combination with solid results from newly acquired Qlogic. Burton believes the combination of the two companies will result in one of the few Communications and Data Center semiconductor pure plays in the market. Burton reiterated his Buy rating on Cavium shares.
11/21/16
JEFF
11/21/16
DOWNGRADE
Target $37
JEFF
Underperform
Mellanox downgraded to Underperform from Hold at Jefferies
Jefferies analyst James Kisner downgraded Mellanox Technologies (MLNX) to Underperform after performing channel checks at a recent trade show. Intel's (INTC) launch of Skylake in the first half of 2017 and possible share loss to Cavium (CAVM) follow its acquisition of QLogic could create "significant incremental pressure" on Mellanox's InfiniBand business, Kisner tells investors in a research note. He cut his price target for the shares to $37 from $42.
LRCX Lam Research
$107.54

0.59 (0.55%)

10/25/16
GSCO
10/25/16
INITIATION
Target $104
GSCO
Neutral
Lam Research reinstated with a Neutral at Goldman
Goldman analyst Toshiya Hari reinstated coverage on Lam Research with a Neutral and a $104 price target.
11/22/16
DADA
11/22/16
NO CHANGE
DADA
Lam Research poised to outperform, says DA Davidson
DA Davidson analyst Thomas Diffely says that Lam Research will continue to outperform, driven by its leverage to the fastest growing segments of the strong semiconductor equipment space. The analyst thinks that the company made "a compelling case" for the sector's strong outlook at its analyst meeting last week. He continues to expect the company to benefit from the proliferation of 3D NAND, and he reiterates a $125 price target and a Buy rating on the shares.
10/21/16
COWN
10/21/16
NO CHANGE
Target $85
COWN
Outperform
KLA-Tencor price target raised to $85 from $80 at Cowen
Cowen analyst Timothy Arcuri raised his price target on KLA-Tencor (KLAC) to $85 from $80 following its strong Q1 results and strong guidance. Arcuri said the company is moving past its failed Lam Research (LRCX) deal and sees standalone partnerships as a significant opportunity. Arcuri said the stock could easily be $90 in the not too distant future and reiterated his Outperform rating on KLA-Tencor shares.
10/20/16
UBSW
10/20/16
NO CHANGE
Target $112
UBSW
Buy
Lam Research solid execution continues, says UBS
UBS analyst Stephen Chin said the solid execution of Lam Research continues and should lead to more growth in 2017. The analyst believes the company has a potential positive catalyst as sales to indigenous fab startups in China is part of Chin's upside case. Chin raised his estimates to reflect raised company guidance and reiterated his Buy rating while raising his price target to $112 from $105 on Lam Research shares.
LOGI Logitech
$24.53

0.13 (0.53%)

10/27/16
BMUR
10/27/16
NO CHANGE
Target $35
BMUR
Buy
Logitech price target raised to $35 from $30 at Brean Capital
Brean Capital analyst Ananda Baruah raised his price target on Logitech to $35 from $30 following its Q2 earnings report. The analyst feels the company will be able to raise its long-term forecast with normalized earnings in the range of $1.50-$2.00 versus the $1.50 when they initiated the shares two days ago. Baruah reiterated his Buy rating on Logitech shares.
10/27/16
10/27/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Long-Term Buy from Buy at Hilliard Lyons. 2. News Corp (NWS) downgraded to Underperform from Neutral at BofA/Merrill with analyst Jessica Reif Cohen saying shares have rallied over the last 3 months and are now within 7% of her $14 price target and the company continues to face significant secular challenges in its News and Information Services segment. 3. Owens Corning (OC) downgraded to Neutral from Buy at CL King. 4. Pearson (PSO) downgraded to Equal Weight from Overweight at Morgan Stanley. 5. Allegiant Travel (ALGT) downgraded to Market Perform from Outperform at Raymond James with analyst Savanthi Syth saying Allegiant's TRASM recovery is likely to take longer than expected while cost pressures during the transition to a single fleet type are likely to increase. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/27/16
10/27/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. GrubHub (GRUB) upgraded to Buy from Neutral at Roth Capital with analyst Darren Aftahi saying he believes delivery is the catalyst for stronger growth, platform stickiness, and growth in earnings before interest, tax, depreciation and amortization per order. 2. Hershey (HSY) upgraded to Buy from Neutral at Citi with analyst David Driscoll citing expectations the shares will rebound in 2017. 3. Owens Corning (OC) downgraded to Neutral from Buy at CL King. 4. Logitech (LOGI) upgraded to Neutral from Underweight at JPMorgan with analyst Paul Coster citing the company's second quarter results. 5. VMware (VMW) upgraded to Buy from Neutral at Citi with analyst Walter Pritchard saying the company's "strong" trends in the third quarter look sustainable. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/27/16
JPMS
10/27/16
UPGRADE
Target $24
JPMS
Neutral
Logitech upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Paul Coster upgraded Logitech to Neutral following the company's Q2 results. The analyst raised his price target for the shares to $24 from $18.
MU Micron
$20.13

0.22 (1.11%)

10/19/16
PACS
10/19/16
NO CHANGE
PACS
Intel data center results bode badly for several stocks, says Pacific Crest
Pacific Crest says that Intel's (INTC) data center results and commentary were "modestly disappointing," as enterprise demand for the company's data center products was "weak," according to the firm. The firm thinks that the negative enterprise results are "modestly negative for stocks with enterprise exposure, including Micron (MU), Seagate (STX) and Western Digital (WDC)."
10/24/16
BARD
10/24/16
NO CHANGE
Target $22
BARD
Outperform
Pricing data points support above consensus estimates for Micron, says Baird
Baird analyst Tristan Gerra said checks indicate further tightening in DRAM while NAND is in shortage with price increases across NAND's three major segments. The analyst believes the data points support his well above consensus 2017 estimates for Micron. Gerra reiterated his Outperform rating and $22 price target on Micron shares.
11/14/16
MSCN
11/14/16
NO CHANGE
MSCN
Micron Q1 revenue estimate raised above consensus at MScience
MScience raised Micron's Q1 revenue estimate above consensus driven by strong DRAM pricing.
11/28/16
DBAB
11/28/16
NO CHANGE
Target $24
DBAB
Buy
Micron price target raised to $24 from $20 at Deutsche Bank
Deutsche Bank analyst Sidney Ho raised his price target for Micron Technology to $24 citing continued strength in DRAM pricing. Further, the analyst expects the upcoming PC DRAM contract negotiations, the closing of the Inotera acquisition and Micron's Q1 results to serve as near term catalysts for the shares. The analyst raised his estimates for the company and reiterates a Buy rating on Micron.
MXIM Maxim Integrated
$40.20

0.24 (0.60%)

11/07/16
RBCM
11/07/16
NO CHANGE
RBCM
Microsemi price target raised to $56 from $48 at RBC Capital
After Bloomberg reported that Microsemi (MSCC) was looking to sell itself, RBC Capital analyst Mitch Steves says that Microsemi could be attractive to many potential acquirers. He names Skyworks (SWKS), Texas Instruments (TXN), Maxim (MXIM) and Broadcom (AVGO) as potential acquirers of Microsemi. However, the analyst thinks that it "may be a bit to early for a deal." Nonetheless, he raised his price target on the name to $56 from $48 and keeps a Top Pick rating on the shares.
10/24/16
RBCM
10/24/16
NO CHANGE
RBCM
Microsemi will be 'a solid target' after debt drops, says RBC Capital
After StreetInsider reported that Microsemi (MSCC) is being "shopped" as a potential semiconductor M&A target, RBC Capital analyst Mitch Steves says that the company would be "a solid target" once its leverage drops to 3.0 times or less from its current 3.7 times. The analyst names Texas Instruments (TXN), Broadcom (AVGO) and Maxim Integrated (MXIM) as potential suitors. He says that Microsemi will "become an attractive M&A target in "2-3 quarters," and he keeps a $48 price target and Top Pick rating on the shares.
09/20/16
SUSQ
09/20/16
INITIATION
Target $50
SUSQ
Positive
Maxim Integrated initiated with a Positive at Susquehanna
Susquehanna analyst Christopher Rolland initiated Maxim with a Positive and a $50 price target saying it has the last valuable analog catalogs that would be desirable for a consolidator
09/07/16
09/07/16
DOWNGRADE
Target $40

Sector Perform
Maxim Integrated downgraded to Sector Perform on valuation at RBC Capital
As previously reported, RBC Capital downgraded Maxim to Sector Perform from Outperform. Analyst Amit Daryanani reduced his rating due to recent share appreciation that reflects self-help cost initiatives and execution, and maintained his $40 price target.
ULTI Ultimate Software
$211.30

2.2 (1.05%)

07/28/16
STFL
07/28/16
NO CHANGE
Target $235
STFL
Buy
Ultimate Software selloff a buying opportunity, says Stifel
Stifel analyst Brad Reback recommends using the selloff in shares of Ultimate Software (ULTI) after Oracle (ORCL) acquired NetSuite (N) as a buying opportunity. In March of 2015, Ultimate Software and NetSuite formed a go-to-market partnership, the analyst points out. The concern is that over time, Oracle would minimize the partnership. Reback remains "quite bullish" on Ultimate's overall market opportunity and he thinks any moves by Oracle would incur in 2017 at the earliest. He has an Outperform rating on the shares with a $235 price target.
09/20/16
PACS
09/20/16
INITIATION
Target $245
PACS
Overweight
Ultimate Software initiated with an Overweight at Pacific Crest
Pacific Crest analyst Trevor Upton started Ultimate Software with an Overweight rating and $245 price target. The company deserves a premium valuation given its "highly predictable" revenue and margin expansion, Upton tells investors in a research note.
10/31/16
WEDB
10/31/16
UPGRADE
Target $242
WEDB
Outperform
Ultimate Software upgraded to Outperform from Neutral at Wedbush
Wedbush analyst Steve Koenig upgraded Ultimate Software to Outperform saying he sees several reasons why the company's initial FY17 revenue guidance will be "surprisingly positive." Consensus FY17 revenue growth expectations of 22% looks "much too low" given the accelerating pace of Ultimate's services revenue, Koenig tells investors in a research note ahead of the company's Q3 results tomorrow. He raised his price target for the shares to $242 from $212.
11/02/16
PACS
11/02/16
NO CHANGE
PACS
Ultimate Software should be boguht on any weakness, says Pacific Crest
After Ultimate reported better than expected Q3 results and raised its 2017 revenue guidance, Pacific Crest analyst Trevor Upton is "encouraged" by the results. The analyst says that the company is "investing for growth." He keeps a $245 price target and Overweight rating.

TODAY'S FREE FLY STORIES

TWTR

Twitter

$17.93

-0.1 (-0.55%)

10:55
12/04/16
12/04
10:55
12/04/16
10:55
Periodicals
Early Twitter investor Sacca would 'love' to see the company sold, CNBC reports »

One of the earliest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

10:55
12/04/16
12/04
10:55
12/04/16
10:55
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$108.14

-1.86 (-1.69%)

10:55
12/04/16
12/04
10:55
12/04/16
10:55
Syndicate
Breaking Syndicate news story on Diamondback Energy »

Diamondback Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

CELG

Celgene

$117.63

-1.24 (-1.04%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Celgene to hold an analyst and investor event »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

INCY

Incyte

$102.02

2.09 (2.09%)

, PFE

Pfizer

$31.63

0.17 (0.54%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

INCY

Incyte

$102.02

2.09 (2.09%)

PFE

Pfizer

$31.63

0.17 (0.54%)

LLY

Eli Lilly

$67.71

1.74 (2.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

  • 15

    Dec

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

, KITE

Kite Pharma

$50.76

0.04 (0.08%)

21:25
12/03/16
12/03
21:25
12/03/16
21:25
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

KITE

Kite Pharma

$50.76

0.04 (0.08%)

BLUE

bluebird bio

$69.75

1.1 (1.60%)

NVS

Novartis

$68.17

0.42 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 06

    Dec

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/03/16
12/03
04:55
12/03/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.